Assessing In-Market Performance: Lessons Learned from an Approved Gene Therapy
Time: 12:15 pm
day: Day 2 REGULATORY AM
Details:
- Presenting a case study on an in-market gene therapy: challenges and strategies in reaching the target patient population
- Lessons learned in improving gene therapy access to patients in a timely manner
- In the context of more gene therapies due to hit the market, how can industry ensure these are covered by insurers?
Speakers:
